Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 31, 2019

SELL
$63.19 - $95.15 $657,555 - $990,130
-10,406 Closed
0 $0
Q1 2019

May 03, 2019

BUY
$90.12 - $152.23 $665,085 - $1.12 Million
7,380 Added 243.89%
10,406 $992,000
Q4 2018

Feb 06, 2019

SELL
$112.83 - $239.74 $279,931 - $594,794
-2,481 Reduced 45.05%
3,026 $376,000
Q3 2018

Nov 13, 2018

BUY
$189.1 - $282.92 $1.04 Million - $1.56 Million
5,507 New
5,507 $1.34 Million
Q2 2018

Aug 09, 2018

SELL
$123.8 - $192.48 $284,121 - $441,741
-2,295 Closed
0 $0
Q1 2018

May 08, 2018

BUY
$114.22 - $133.22 $262,134 - $305,739
2,295 New
2,295 $282,000
Q4 2017

Feb 13, 2018

SELL
$93.4 - $128.74 $353,332 - $487,023
-3,783 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$91.08 - $104.49 $344,555 - $395,285
3,783
3,783 $360,000

Others Institutions Holding INGN

About Inogen Inc


  • Ticker INGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 22,866,500
  • Market Cap $214M
  • Description
  • Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...
More about INGN
Track This Portfolio

Track Stevens Capital Management LP Portfolio

Follow Stevens Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.